SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 131 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,385,000 | -2.3% | 1,403,149 | 0.0% | 0.17% | -2.4% |
| Q2 2018 | $2,441,000 | -3.1% | 1,403,149 | +1.9% | 0.17% | -14.6% |
| Q1 2018 | $2,519,000 | +8.4% | 1,376,708 | +32.2% | 0.20% | +32.7% |
| Q4 2017 | $2,323,000 | +4.1% | 1,041,695 | +35.4% | 0.15% | +3.4% |
| Q3 2017 | $2,231,000 | -69.1% | 769,140 | -52.6% | 0.14% | -70.6% |
| Q2 2017 | $7,225,000 | -30.7% | 1,623,623 | -27.4% | 0.49% | -14.0% |
| Q1 2017 | $10,428,000 | +9.2% | 2,237,701 | +42.7% | 0.57% | +24.0% |
| Q4 2016 | $9,552,000 | +5.8% | 1,568,487 | -4.3% | 0.46% | +11.6% |
| Q3 2016 | $9,028,000 | +48.2% | 1,638,410 | +2.2% | 0.41% | +23.6% |
| Q2 2016 | $6,093,000 | +368.3% | 1,603,334 | +598.9% | 0.34% | +431.7% |
| Q4 2015 | $1,301,000 | -27.8% | 229,420 | -32.5% | 0.06% | -27.6% |
| Q3 2015 | $1,802,000 | +8.6% | 340,000 | +70.0% | 0.09% | +33.8% |
| Q2 2015 | $1,660,000 | – | 200,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |